News Briefs: Centene Completes Acquisition of Magellan Health | Jan. 6, 2022

Centene Corp. completed its $2.2 billion acquisition of Magellan Health, Inc. The previously announced deal will allow Centene to expand its behavioral health platform, increase its specialty health and pharmacy capabilities, and enhance its ability to address members’ whole health. Magellan Health will operate independently under Centene’s Health Care Enterprises umbrella, with CEO Ken Fasola and other members of Magellan Health’s leadership team continuing to lead the organization, Centene said on Jan. 4.

© 2022 MMIT

Lauren Flynn Kelly Managing Editor, Radar on Medicare Advantage

Lauren has been covering health business issues, including drug benefits and specialty pharmacy, for more than a decade. She served as editor of Drug Benefit News (the predecessor to Radar on Drug Benefits) from 2004 to 2005 and again from 2011 to 2016, and now manages Radar on Medicare Advantage. Lauren graduated from Vassar College with a B.A. in English.

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2022/01/WordPress-Featured-Image_AdobeStock_446112846.jpg
January 20

Sweeping Rule Raises Onus on MAOs, Seeks Pharmacy DIR Reform

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2022/01/WordPress-Featured_AdobeStock_338182899.jpg
January 20

2022 Outlook: MA Insurer Execs Plan Investments Supporting Equity, SDOH

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2022/01/WordPress-Featured_AdobeStock_232017474.jpg
January 20

As Medicaid Enrollment Soars, States Ask MCOs to Intensify Social Determinants of Health Efforts

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today